NDA 006134 · Hikma
Dolophine Hydrochloride
Methadone Hydrochloride · Oral
DiscontinuedLast checked: Nov 20, 2026Latest source record: Jun 2, 2021 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1947
Aug 13, 1947
Approved uses
1
Original approval plus efficacy supplements
Registered trials
340
70 Phase 3, 35 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Aug 13, 1947 Original approval Other Important Information from FDAOther
3 products under this application
- DOLOPHINE HYDROCHLORIDE · METHADONE HYDROCHLORIDE 10MG/30ML · SYRUP, ORAL · Discontinued
- DOLOPHINE HYDROCHLORIDE · METHADONE HYDROCHLORIDE 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, ORAL · Discontinued
- DOLOPHINE HYDROCHLORIDE · METHADONE HYDROCHLORIDE 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, ORAL · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Methadone" as an intervention, any sponsor and status, largest first.
Vanderbilt UniversityAcademic, hospital or other
NCT02625181 · 27,034 participants · Start Jul 2016 · Primary completion Nov 2, 2017
Drug: Propofol; Sevoflurane and 28 more · For: Postoperative Nausea and Vomiting
Sites: Nashville, Tennessee
- MAST Trial: Multi-modal Analgesic Strategies in TraumaPivotal-lookingCompleted
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT03472469 · 1,561 participants · Start Apr 2, 2018 · Primary completion Jul 3, 2019
Drug: Acetaminophen IV/PO; Acetaminophen PO and 9 more · For: Nonspecific Pain Post Traumatic Injury
Sites: Houston, Texas
- Combined Therapy of Methadone and DextromethrophanPivotal-lookingStatus unknown
National Cheng-Kung University HospitalAcademic, hospital or other
NCT01189097 · 1,500 participants (planned) · Start Apr 2008 · Primary completion Mar 2011
Drug: Dextromethorphan; Dextromethorphan · For: Opioid Abuse
Sites: Tainan, Taiwan
- Starting Treatment With Agonist Replacement Therapies (START)Pivotal-lookingCompleted
University of California, Los AngelesAcademic, hospital or other
NCT00315341 · 1,269 participants · Start Apr 2006 · Primary completion Aug 2010
Drug: Buprenorphine/naloxone; Methadone · For: Opiate-related Disorders
Sites: Los Angeles, California; Sacramento, California; San Francisco, California · 9 sites in all
- The German Project of Heroin Assisted Treatment of Opiate Dependent PatientsPivotal-lookingCompleted
Universitätsklinikum Hamburg-EppendorfAcademic, hospital or other
NCT00268814 · 1,015 participants · Start Mar 2002 · Primary completion Dec 2003
Drug: Diacetylmorphine; Methadone · For: Opioid Dependence
Sites: Karlsruhe, Germany; Munich, Germany; Hamburg, Germany · 7 sites in all
- Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)Pivotal-lookingCompleted
Duke UniversityAcademic, hospital or other
NCT03726268 · 907 participants · Start Nov 29, 2018 · Primary completion Jul 30, 2023
Drug: Methadone; Fentanyl and 3 more · For: Opioid Use; Pain, Postoperative
Sites: Durham, North Carolina
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.Pivotal-lookingRecruiting
Yale UniversityAcademic, hospital or other
NCT06323824 · 600 participants (planned) · Start Jun 4, 2024 · Primary completion Dec 2028
Drug: Methadone; Buprenorphine (BUP) · For: Opioid Use Disorder
Sites: Oakland, California; San Francisco, California; Denver, Colorado · 6 sites in all
- Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After DetoxificationPivotal-lookingCompleted
Shanghai Mental Health CenterAcademic, hospital or other
NCT01580163 · 554 participants · Start Sep 2009 · Primary completion Aug 2013
Drug: JITAI Combined with psychological intervention; Methadone and 1 more · For: Heroin Addiction
Sites: Beijing, China; Changsha, China
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.
Degenhardt L, Clark B, Macpherson G, et al. · Lancet Psychiatry 2023 · Meta-Analysis, Systematic Review
- Intraoperative methadone administration and postoperative pain control: a systematic review and meta-analysis.
D'Souza RS, Gurrieri C, Johnson RL, et al. · Pain 2020 · Meta-Analysis, Systematic Review
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Sordo L, Barrio G, Bravo MJ, et al. · BMJ 2017 · Meta-Analysis, Systematic Review
- Shifting Views on Cancer Pain Management: A Systematic Review and Network Meta-Analysis.
Imkamp MSV, Theunissen M, Viechtbauer W, et al. · J Pain Symptom Manage 2024 · Systematic Review, Network Meta-Analysis
- Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis.
Kinsella M, Halliday LOE, Shaw M, et al. · Subst Use Misuse 2022 · Meta-Analysis, Systematic Review
- Neuropsychological functioning and chronic methadone use: A systematic review and meta-analysis.
Baldacchino A, Armanyous M, Balfour DJ, et al. · Neurosci Biobehav Rev 2017 · Meta-Analysis, Systematic Review
Sponsor: Hikma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.